C vs TERN
Citigroup Inc. (C) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
C currently screens at market cap $214.73B and trailing P/E 15.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the C and TERN stock pages for the full models.
Not investment advice.